Home > Food & Beverages > Proteins > Alternative Proteins > Antimicrobial (Enzymatic) Protein Hydrolysates Market

Antimicrobial (Enzymatic) Protein Hydrolysates Market Trends

Report ID: GMI5285
Published Date: Dec 2024
Report Format: PDF

Download Free Sample

Antimicrobial Protein Hydrolysates Market Trends for Food & Pet Food Applications

The antimicrobial (enzymatic) protein hydrolysates industry for food & pet food applications is witnessing a shift toward sustainable and bio-based solutions as consumers and industries prioritize natural ingredients. Increasing use in food preservation, pharmaceuticals, and cosmetics is driven by their effectiveness in inhibiting microbial growth while maintaining product safety. There is also growing research into the development of hydrolysates from various protein sources like soy, fish, and milk, broadening their applications.

Technological advancements in enzyme processing are improving production efficiency, making these hydrolysates more accessible. Additionally, the market is seeing increased interest from the nutraceutical and animal feed sectors for their dual benefits of antimicrobial properties and nutritional enhancement.

Authors: Kiran Pulidindi, Kunal Ahuja

Frequently Asked Questions (FAQ) :

The market size for antimicrobial (enzymatic) protein hydrolysates in food and pet food applications reached USD 256.2 million in 2024 and is set to grow at a 7.4% CAGR from 2025 to 2034, driven by increasing demand for natural and bio-based antimicrobial agents.

The powder form segment held a dominant market share of 63% in 2024, as its stability makes it easier to transport and handle in various industrial applications.

The U.S. market was valued at USD 57.9 million in 2024, led by increasing consumer preference for natural, clean-label ingredients.

Key players include A Constantino & C Spa, Aker Biomarine, AMCO Proteins, Biomega Group, BRF Ingredients, Cargill Incorporated, Crescent Biotech, IQI Petfood, Kemin Industries, and Kerry Group.